Lazard Asset Management’s Ingevity NGVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $660K | Buy |
9,262
+549
| +6% | +$37.5K | ﹤0.01% | 1296 |
|
|
2025
Q4 | $516K | Hold |
8,713
| – | – | ﹤0.01% | 1371 |
|
|
2025
Q3 | $481K | Sell |
8,713
-30,333
| -78% | -$1.58M | ﹤0.01% | 1360 |
|
|
2025
Q2 | $1.68M | Buy |
39,046
+34,631
| +784% | +$1.34M | ﹤0.01% | 1073 |
|
|
2025
Q1 | $173K | Buy |
4,415
+4,304
| +3,877% | +$190K | ﹤0.01% | 1660 |
|
|
2024
Q4 | $4K | Sell |
111
-174,167
| -100% | -$7.25M | ﹤0.01% | 2147 |
|
|
2024
Q3 | $6.8M | Buy |
174,278
+24,048
| +16% | +$958K | 0.01% | 557 |
|
|
2024
Q2 | $6.57M | Buy |
150,230
+16,762
| +13% | +$810K | 0.01% | 612 |
|
|
2024
Q1 | $6.37M | Sell |
133,468
-157,815
| -54% | -$7.09M | 0.01% | 638 |
|
|
2023
Q4 | $13.8M | Sell |
291,283
-33,914
| -10% | -$1.41M | 0.02% | 477 |
|
|
2023
Q3 | $15.5M | Sell |
325,197
-88,174
| -21% | -$4.81M | 0.02% | 444 |
|
|
2023
Q2 | $24M | Sell |
413,371
-10,449
| -2% | -$627K | 0.03% | 361 |
|
|
2023
Q1 | $30.3M | Sell |
423,820
-32,853
| -7% | -$2.61M | 0.04% | 315 |
|
|
2022
Q4 | $32.2M | Sell |
456,673
-74,852
| -14% | -$5.28M | 0.04% | 296 |
|
|
2022
Q3 | $32.2M | Sell |
531,525
-64,513
| -11% | -$4.33M | 0.05% | 297 |
|
|
2022
Q2 | $37.6M | Sell |
596,038
-16,045
| -3% | -$1.05M | 0.05% | 284 |
|
|
2022
Q1 | $39.2M | Sell |
612,083
-28,049
| -4% | -$1.88M | 0.05% | 326 |
|
|
2021
Q4 | $45.9M | Sell |
640,132
-49,713
| -7% | -$3.78M | 0.05% | 304 |
|
|
2021
Q3 | $49.2M | Sell |
689,845
-17,143
| -2% | -$1.35M | 0.06% | 284 |
|
|
2021
Q2 | $57.5M | Buy |
706,988
+2,064
| +0.3% | +$166K | 0.06% | 251 |
|
|
2021
Q1 | $53.2M | Sell |
704,924
-57,028
| -7% | -$4.15M | 0.06% | 236 |
|
|
2020
Q4 | $57.7M | Buy |
761,952
+41,775
| +6% | +$2.72M | 0.07% | 215 |
|
|
2020
Q3 | $35.6M | Sell |
720,177
-20,538
| -3% | -$1.16M | 0.05% | 283 |
|
|
2020
Q2 | $38.9M | Buy |
740,715
+96,985
| +15% | +$4.6M | 0.06% | 220 |
|
|
2020
Q1 | $22.7M | Buy |
643,730
+177,501
| +38% | +$10.4M | 0.04% | 286 |
|
|
2019
Q4 | $40.7M | Buy |
466,229
+19,591
| +4% | +$1.71M | 0.06% | 210 |
|
|
2019
Q3 | $37.9M | Buy |
446,638
+50,510
| +13% | +$4.5M | 0.06% | 216 |
|
|
2019
Q2 | $41.7M | Buy |
396,128
+100,145
| +34% | +$10.1M | 0.07% | 201 |
|
|
2019
Q1 | $31.3M | Sell |
295,983
-66,930
| -18% | -$6.72M | 0.05% | 240 |
|
|
2018
Q4 | $30.4M | Sell |
362,913
-140,440
| -28% | -$12.7M | 0.06% | 219 |
|
|
2018
Q3 | $51.3M | Buy |
503,353
+10,620
| +2% | +$1.03M | 0.08% | 170 |
|
|
2018
Q2 | $39.8M | Buy |
492,733
+44,059
| +10% | +$3.5M | 0.07% | 194 |
|
|
2018
Q1 | $33.1M | Sell |
448,674
-64,770
| -13% | -$4.85M | 0.06% | 220 |
|
|
2017
Q4 | $36.2M | Buy |
513,444
+6,908
| +1% | +$498K | 0.06% | 211 |
|
|
2017
Q3 | $31.6M | Sell |
506,536
-37,001
| -7% | -$2.19M | 0.06% | 221 |
|
|
2017
Q2 | $31.2M | Sell |
543,537
-72,605
| -12% | -$4.27M | 0.06% | 222 |
|
|
2017
Q1 | $37.5M | Sell |
616,142
-142,858
| -19% | -$8.08M | 0.07% | 187 |
|
|
2016
Q4 | $41.6M | Buy |
759,000
+176,731
| +30% | +$8.48M | 0.08% | 165 |
|
|
2016
Q3 | $26.8M | Sell |
582,269
-285,027
| -33% | -$12M | 0.05% | 213 |
|
|
2016
Q2 | $29.5M | Buy |
+867,296
| New | +$27.1M | 0.06% | 192 |
|
Other funds holding NGVT
VPM
VCM
SBH
SCM
Lazard Asset Management's NGVT Position: Q1 2026 in Review
Lazard Asset Management increased its Ingevity (NGVT) stake by 6.3% in Q1 2026, buying an estimated $37.5K and bringing the position to 9,262 shares worth $660K. The position accounts for ﹤0.01% of the portfolio, ranked #1296.
Lazard Asset Management first reported a position in NGVT in Q2 2016 and has held it in 40 quarters since. The position peaked at $57.7M in Q4 2020. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.
- Lazard Asset Management held 9,262 shares of Ingevity worth $660K as of Q1 2026.
- Lazard Asset Management bought 549 Ingevity shares in Q1 2026, an estimated $37.5K.
- Ingevity made up ﹤0.01% of Lazard Asset Management's portfolio in Q1 2026, its #1296 holding.
- Lazard Asset Management first reported a position in Ingevity in Q2 2016 and has held it in 40 quarters since.
- Lazard Asset Management's Ingevity position peaked at $57.7M in Q4 2020.
- 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.
Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.